Become a Member
The Jewish Chronicle

Hope for sufferers of glaucoma

July 10, 2008 23:00

By

Rachel Fletcher

3 min read

Glaucoma treatment could move forward significantly after positive results in a clinical study for a laser-based technique that does not penetrate the eye membrane.

BioIsrael reports how IOPtima, a subsidiary of Bio-Light Life Science Investments in Ramat Gan, just outside Tel Aviv, successfully completed the three-month follow-up period in an initial human clinical study with its OT134 device.

The treatment allows eye surgeons to operate and reduce internal eye pressure with the membrane intact.

BioIsrael quoted IOPtima CEO Joshua Degani as claiming the technique “could revolutionise the way glaucoma is treated”.